Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,131.42
+6.15 (0.55%)
At close: Jun 5, 2026, 4:00 PM EDT
1,122.13
-9.30 (-0.82%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Eli Lilly and Company Employees
Eli Lilly and Company had 50,000 employees as of December 31, 2025. The number of employees increased by 3,000 or 6.38% compared to the previous year.
Employees
50,000
Change (1Y)
3,000
Growth (1Y)
6.38%
Revenue / Employee
$1,444,980
Profits / Employee
$505,540
Market Cap
1.01T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 50,000 | 3,000 | 6.38% |
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
| Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
| Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
| Dec 31, 2016 | 41,975 | 700 | 1.70% |
| Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
| Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
| Dec 31, 2013 | 37,925 | -425 | -1.11% |
| Dec 31, 2012 | 38,350 | 270 | 0.71% |
| Dec 31, 2011 | 38,080 | -270 | -0.70% |
| Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
| Dec 31, 2009 | 40,360 | -140 | -0.35% |
| Dec 31, 2008 | 40,500 | -100 | -0.25% |
| Dec 31, 2007 | 40,600 | -900 | -2.17% |
| Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
| Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
| Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
| Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
| Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
| Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
| Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
| Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
| Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
| Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
| Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
| Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
| Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
| Dec 31, 1993 | 32,700 | 500 | 1.55% |
| Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
| Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
| Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
| Dec 31, 1989 | 27,800 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| AbbVie | 57,000 |
LLY News
- 1 hour ago - Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits - Reuters
- 1 hour ago - Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications - PRNewsWire
- 1 day ago - Jim Cramer Sees Eli Lilly (LLY) Delivering ‘Knockout Punch’ to Competitors - TipRanks
- 1 day ago - No tech, no problem. Dow makes record and traders think these stocks can lead now - CNBC
- 2 days ago - Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup - Forbes
- 3 days ago - Lilly to halve planned €2.3 billion investment in Germany, CEO tells newspaper - Reuters
- 3 days ago - ‘Expect More Acquisitions,’ Says Eli Lilly’s (LLY) Top Dealmaker - TipRanks
- 3 days ago - Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal - WSJ